APO Research
Talk to an analyst

APO RESEARCH · REPORT

Ophthalmic AI-assisted Diagnosis

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Ophthalmic AI-assisted Diagnosis Market Outlook and Growth Opportunities 2026

6 March 2026192 pages

Choose your research edition.

Industry ResearchOphthalmic AI-assisted Diagnosis Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Ophthalmic AI-assisted Diagnosis Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Ophthalmic AI-assisted Diagnosis Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ophthalmic AI-assisted Diagnosis Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Ophthalmic AI-assisted Diagnosis Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Ophthalmic AI-assisted Diagnosis market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Ophthalmic AI-assisted Diagnosis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Ophthalmic AI-assisted Diagnosis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Ophthalmic AI-assisted Diagnosis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Ophthalmic AI-assisted Diagnosis market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Ophthalmic AI-assisted Diagnosis market include Baidu Lingyi, Tencent Health, VoxelCloud, Wision, ZHENHEALTH, Acer Medical, IMLINCS, Vistel and Airdoc, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Ophthalmic AI-assisted Diagnosis market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Ophthalmic AI-assisted Diagnosis and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Ophthalmic AI-assisted Diagnosis revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Ophthalmic AI-assisted Diagnosis market.

Ophthalmic AI-assisted Diagnosis Segment by Company

Baidu Lingyi

Tencent Health

VoxelCloud

Wision

ZHENHEALTH

Acer Medical

IMLINCS

Vistel

Airdoc

Shenzhen SiSensing

WeDoctor

Altris, Inc

Ophthalmic AI-assisted Diagnosis Segment by Type

Cloud-based

On-Primes

Ophthalmic AI-assisted Diagnosis Segment by Application

Hospital

Clinic

Imaging Center

Ophthalmic AI-assisted Diagnosis Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Ophthalmic AI-assisted Diagnosis status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Ophthalmic AI-assisted Diagnosis key companies, revenue, market share, and recent developments.

3. To split the Ophthalmic AI-assisted Diagnosis breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Ophthalmic AI-assisted Diagnosis market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Ophthalmic AI-assisted Diagnosis significant trends, drivers, influence factors in global and regions.

6. To analyze Ophthalmic AI-assisted Diagnosis competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ophthalmic AI-assisted Diagnosis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ophthalmic AI-assisted Diagnosis and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ophthalmic AI-assisted Diagnosis.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Ophthalmic AI-assisted Diagnosis industry.

Chapter 3: Detailed analysis of Ophthalmic AI-assisted Diagnosis company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Ophthalmic AI-assisted Diagnosis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Ophthalmic AI-assisted Diagnosis in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Ophthalmic AI-assisted Diagnosis Industry Trends Table 2. Ophthalmic AI-assisted Diagnosis Industry Drivers Table 3. Ophthalmic AI-assisted Diagnosis Industry Opportunities and Challenges Table 4. Ophthalmic AI-assisted Diagnosis Industry Restraints Table 5. Global Ophthalmic AI-assisted Diagnosis Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Ophthalmic AI-assisted Diagnosis Revenue Share by Company (2021-2026) Table 7. Global Ophthalmic AI-assisted Diagnosis Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Ophthalmic AI-assisted Diagnosis Key Company Manufacturing Base & Headquarters Table 9. Global Ophthalmic AI-assisted Diagnosis Company, Product Type & Application Table 10. Global Ophthalmic AI-assisted Diagnosis Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Ophthalmic AI-assisted Diagnosis by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Cloud-based Table 15. Significant Companies of On-Primes Table 16. Global Ophthalmic AI-assisted Diagnosis Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Ophthalmic AI-assisted Diagnosis Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Ophthalmic AI-assisted Diagnosis Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Ophthalmic AI-assisted Diagnosis Sales Value Share by Type (2021-2026) Table 20. Global Ophthalmic AI-assisted Diagnosis Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Hospital Table 22. Significant Companies of Clinic Table 23. Significant Companies of Imaging Center Table 24. Global Ophthalmic AI-assisted Diagnosis Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Ophthalmic AI-assisted Diagnosis Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Ophthalmic AI-assisted Diagnosis Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Ophthalmic AI-assisted Diagnosis Sales Value Share by Application (2021-2026) Table 28. Global Ophthalmic AI-assisted Diagnosis Sales Value Share by Application (2027-2032) Table 29. Global Ophthalmic AI-assisted Diagnosis Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Ophthalmic AI-assisted Diagnosis Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Ophthalmic AI-assisted Diagnosis Sales Value Share by Region (2021-2026) Table 32. Global Ophthalmic AI-assisted Diagnosis Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Ophthalmic AI-assisted Diagnosis Sales Value Share by Region (2027-2032) Table 34. Global Ophthalmic AI-assisted Diagnosis Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Ophthalmic AI-assisted Diagnosis Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Ophthalmic AI-assisted Diagnosis Sales Value Market Share by Country (2021-2026) Table 37. Global Ophthalmic AI-assisted Diagnosis Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Ophthalmic AI-assisted Diagnosis Sales Value Market Share by Country (2027-2032) Table 39. Baidu Lingyi Company Information Table 40. Baidu Lingyi Business Overview Table 41. Baidu Lingyi Ophthalmic AI-assisted Diagnosis Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Baidu Lingyi Ophthalmic AI-assisted Diagnosis Product Portfolio Table 43. Baidu Lingyi Recent Development Table 44. Tencent Health Company Information Table 45. Tencent Health Business Overview Table 46. Tencent Health Ophthalmic AI-assisted Diagnosis Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Tencent Health Ophthalmic AI-assisted Diagnosis Product Portfolio Table 48. Tencent Health Recent Development Table 49. VoxelCloud Company Information Table 50. VoxelCloud Business Overview Table 51. VoxelCloud Ophthalmic AI-assisted Diagnosis Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. VoxelCloud Ophthalmic AI-assisted Diagnosis Product Portfolio Table 53. VoxelCloud Recent Development Table 54. Wision Company Information Table 55. Wision Business Overview Table 56. Wision Ophthalmic AI-assisted Diagnosis Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Wision Ophthalmic AI-assisted Diagnosis Product Portfolio Table 58. Wision Recent Development Table 59. ZHENHEALTH Company Information Table 60. ZHENHEALTH Business Overview Table 61. ZHENHEALTH Ophthalmic AI-assisted Diagnosis Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. ZHENHEALTH Ophthalmic AI-assisted Diagnosis Product Portfolio Table 63. ZHENHEALTH Recent Development Table 64. Acer Medical Company Information Table 65. Acer Medical Business Overview Table 66. Acer Medical Ophthalmic AI-assisted Diagnosis Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Acer Medical Ophthalmic AI-assisted Diagnosis Product Portfolio Table 68. Acer Medical Recent Development Table 69. IMLINCS Company Information Table 70. IMLINCS Business Overview Table 71. IMLINCS Ophthalmic AI-assisted Diagnosis Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. IMLINCS Ophthalmic AI-assisted Diagnosis Product Portfolio Table 73. IMLINCS Recent Development Table 74. Vistel Company Information Table 75. Vistel Business Overview Table 76. Vistel Ophthalmic AI-assisted Diagnosis Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Vistel Ophthalmic AI-assisted Diagnosis Product Portfolio Table 78. Vistel Recent Development Table 79. Airdoc Company Information Table 80. Airdoc Business Overview Table 81. Airdoc Ophthalmic AI-assisted Diagnosis Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Airdoc Ophthalmic AI-assisted Diagnosis Product Portfolio Table 83. Airdoc Recent Development Table 84. Shenzhen SiSensing Company Information Table 85. Shenzhen SiSensing Business Overview Table 86. Shenzhen SiSensing Ophthalmic AI-assisted Diagnosis Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Shenzhen SiSensing Ophthalmic AI-assisted Diagnosis Product Portfolio Table 88. Shenzhen SiSensing Recent Development Table 89. WeDoctor Company Information Table 90. WeDoctor Business Overview Table 91. WeDoctor Ophthalmic AI-assisted Diagnosis Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. WeDoctor Ophthalmic AI-assisted Diagnosis Product Portfolio Table 93. WeDoctor Recent Development Table 94. Altris, Inc Company Information Table 95. Altris, Inc Business Overview Table 96. Altris, Inc Ophthalmic AI-assisted Diagnosis Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. Altris, Inc Ophthalmic AI-assisted Diagnosis Product Portfolio Table 98. Altris, Inc Recent Development Table 99. Research Programs/Design for This Report Table 100. Authors List of This Report Table 101. Secondary Sources Table 102. Primary Sources List of Figures Figure 1. Ophthalmic AI-assisted Diagnosis Product Image Figure 2. Global Ophthalmic AI-assisted Diagnosis Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ophthalmic AI-assisted Diagnosis Market Size (2021-2032) & (US$ Million) Figure 4. Global Ophthalmic AI-assisted Diagnosis Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Cloud-based Image Figure 8. On-Primes Image Figure 9. Global Ophthalmic AI-assisted Diagnosis Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Ophthalmic AI-assisted Diagnosis Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Ophthalmic AI-assisted Diagnosis Sales Value Share by Type (2021-2032) Figure 12. Hospital Image Figure 13. Clinic Image Figure 14. Imaging Center Image Figure 15. Global Ophthalmic AI-assisted Diagnosis Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Ophthalmic AI-assisted Diagnosis Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Ophthalmic AI-assisted Diagnosis Sales Value Share by Application (2021-2032) Figure 18. Global Ophthalmic AI-assisted Diagnosis Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Ophthalmic AI-assisted Diagnosis Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Ophthalmic AI-assisted Diagnosis Sales Value (2021-2032) & (US$ Million) Figure 21. North America Ophthalmic AI-assisted Diagnosis Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Ophthalmic AI-assisted Diagnosis Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Ophthalmic AI-assisted Diagnosis Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Ophthalmic AI-assisted Diagnosis Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Ophthalmic AI-assisted Diagnosis Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Ophthalmic AI-assisted Diagnosis Sales Value (2021-2032) & (US$ Million) Figure 27. South America Ophthalmic AI-assisted Diagnosis Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Ophthalmic AI-assisted Diagnosis Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Ophthalmic AI-assisted Diagnosis Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Ophthalmic AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Ophthalmic AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Ophthalmic AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Ophthalmic AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Ophthalmic AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Ophthalmic AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Ophthalmic AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Ophthalmic AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Ophthalmic AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Ophthalmic AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Ophthalmic AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Ophthalmic AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Ophthalmic AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Ophthalmic AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Ophthalmic AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Ophthalmic AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Ophthalmic AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Ophthalmic AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Ophthalmic AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Ophthalmic AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Ophthalmic AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Ophthalmic AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Ophthalmic AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Ophthalmic AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Ophthalmic AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Ophthalmic AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Ophthalmic AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Ophthalmic AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Ophthalmic AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Ophthalmic AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Ophthalmic AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Ophthalmic AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Ophthalmic AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Ophthalmic AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Ophthalmic AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Ophthalmic AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Ophthalmic AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Ophthalmic AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Ophthalmic AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Ophthalmic AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Ophthalmic AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Ophthalmic AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Ophthalmic AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Ophthalmic AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Ophthalmic AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Ophthalmic AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Ophthalmic AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Ophthalmic AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Ophthalmic AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Ophthalmic AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Ophthalmic AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Ophthalmic AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Ophthalmic AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Ophthalmic AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Ophthalmic AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Ophthalmic AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Ophthalmic AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Ophthalmic AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Ophthalmic AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Ophthalmic AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Ophthalmic AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Ophthalmic AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Ophthalmic AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Ophthalmic AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Ophthalmic AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Ophthalmic AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Ophthalmic AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Ophthalmic AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Ophthalmic AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Ophthalmic AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Ophthalmic AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Ophthalmic AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Ophthalmic AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Ophthalmic AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Ophthalmic AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Ophthalmic AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Ophthalmic AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Ophthalmic AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Ophthalmic AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Ophthalmic AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Ophthalmic AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Ophthalmic AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Ophthalmic AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Ophthalmic AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Cloud-based
  • On-Primes
Applications
  • Hospital
  • Clinic
  • Imaging Center
Companies covered
  • Baidu Lingyi
  • Tencent Health
  • VoxelCloud
  • Wision
  • ZHENHEALTH
  • Acer Medical
  • IMLINCS
  • Vistel
  • Airdoc
  • Shenzhen SiSensing
  • WeDoctor
  • Altris, Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Ophthalmic AI-assisted Diagnosis Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Ophthalmic AI-assisted Diagnosis Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Ophthalmic AI-assisted Diagnosis Market Dynamics
  1. 2.1 Ophthalmic AI-assisted Diagnosis Industry Trends
  2. 2.2 Ophthalmic AI-assisted Diagnosis Industry Drivers
  3. 2.3 Ophthalmic AI-assisted Diagnosis Industry Opportunities and Challenges
  4. 2.4 Ophthalmic AI-assisted Diagnosis Industry Restraints
3 Ophthalmic AI-assisted Diagnosis Market by Company
  1. 3.1 Global Ophthalmic AI-assisted Diagnosis Company Revenue Ranking in 2025
  2. 3.2 Global Ophthalmic AI-assisted Diagnosis Revenue by Company (2021-2026)
  3. 3.3 Global Ophthalmic AI-assisted Diagnosis Company Ranking (2024-2026)
  4. 3.4 Global Ophthalmic AI-assisted Diagnosis Company Manufacturing Base and Headquarters
  5. 3.5 Global Ophthalmic AI-assisted Diagnosis Company Product Type and Application
  6. 3.6 Global Ophthalmic AI-assisted Diagnosis Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Ophthalmic AI-assisted Diagnosis Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Ophthalmic AI-assisted Diagnosis Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Ophthalmic AI-assisted Diagnosis Market by Type
  1. 4.1 Ophthalmic AI-assisted Diagnosis Type Introduction
  2. 4.1.1 Cloud-based
  3. 4.1.2 On-Primes
  4. 4.2 Global Ophthalmic AI-assisted Diagnosis Sales Value by Type
  5. 4.2.1 Global Ophthalmic AI-assisted Diagnosis Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Ophthalmic AI-assisted Diagnosis Sales Value by Type (2021-2032)
  7. 4.2.3 Global Ophthalmic AI-assisted Diagnosis Sales Value Share by Type (2021-2032)
5 Ophthalmic AI-assisted Diagnosis Market by Application
  1. 5.1 Ophthalmic AI-assisted Diagnosis Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Imaging Center
  5. 5.2 Global Ophthalmic AI-assisted Diagnosis Sales Value by Application
  6. 5.2.1 Global Ophthalmic AI-assisted Diagnosis Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Ophthalmic AI-assisted Diagnosis Sales Value by Application (2021-2032)
  8. 5.2.3 Global Ophthalmic AI-assisted Diagnosis Sales Value Share by Application (2021-2032)
6 Ophthalmic AI-assisted Diagnosis Regional Value Analysis
  1. 6.1 Global Ophthalmic AI-assisted Diagnosis Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Ophthalmic AI-assisted Diagnosis Sales Value by Region (2021-2032)
  3. 6.2.1 Global Ophthalmic AI-assisted Diagnosis Sales Value by Region: 2021-2026
  4. 6.2.2 Global Ophthalmic AI-assisted Diagnosis Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Ophthalmic AI-assisted Diagnosis Sales Value (2021-2032)
  7. 6.3.2 North America Ophthalmic AI-assisted Diagnosis Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Ophthalmic AI-assisted Diagnosis Sales Value (2021-2032)
  10. 6.4.2 Europe Ophthalmic AI-assisted Diagnosis Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Ophthalmic AI-assisted Diagnosis Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Ophthalmic AI-assisted Diagnosis Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Ophthalmic AI-assisted Diagnosis Sales Value (2021-2032)
  16. 6.6.2 South America Ophthalmic AI-assisted Diagnosis Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Ophthalmic AI-assisted Diagnosis Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Ophthalmic AI-assisted Diagnosis Sales Value Share by Country, 2025 VS 2032
7 Ophthalmic AI-assisted Diagnosis Country-level Value Analysis
  1. 7.1 Global Ophthalmic AI-assisted Diagnosis Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Ophthalmic AI-assisted Diagnosis Sales Value by Country (2021-2032)
  3. 7.2.1 Global Ophthalmic AI-assisted Diagnosis Sales Value by Country (2021-2026)
  4. 7.2.2 Global Ophthalmic AI-assisted Diagnosis Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Ophthalmic AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Ophthalmic AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Ophthalmic AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Ophthalmic AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Ophthalmic AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Ophthalmic AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Ophthalmic AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Ophthalmic AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Ophthalmic AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Ophthalmic AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Ophthalmic AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Ophthalmic AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Ophthalmic AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Ophthalmic AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Ophthalmic AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Ophthalmic AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Ophthalmic AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Ophthalmic AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Ophthalmic AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Ophthalmic AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Ophthalmic AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Ophthalmic AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Ophthalmic AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Ophthalmic AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Ophthalmic AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Ophthalmic AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Ophthalmic AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Ophthalmic AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Ophthalmic AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Ophthalmic AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Ophthalmic AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Ophthalmic AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Ophthalmic AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Ophthalmic AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Ophthalmic AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Ophthalmic AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Ophthalmic AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Ophthalmic AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Ophthalmic AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Ophthalmic AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Ophthalmic AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Ophthalmic AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Ophthalmic AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Ophthalmic AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Ophthalmic AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Ophthalmic AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Ophthalmic AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Ophthalmic AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Ophthalmic AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Ophthalmic AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Ophthalmic AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Ophthalmic AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Ophthalmic AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Ophthalmic AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Ophthalmic AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Ophthalmic AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Ophthalmic AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Ophthalmic AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Ophthalmic AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Ophthalmic AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Ophthalmic AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Ophthalmic AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Ophthalmic AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Ophthalmic AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Ophthalmic AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Ophthalmic AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Ophthalmic AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Ophthalmic AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Ophthalmic AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Ophthalmic AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Ophthalmic AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Ophthalmic AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Ophthalmic AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Ophthalmic AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Ophthalmic AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Ophthalmic AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Ophthalmic AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Ophthalmic AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Ophthalmic AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Ophthalmic AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Ophthalmic AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Ophthalmic AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Ophthalmic AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Ophthalmic AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Baidu Lingyi
  2. 8.1.1 Baidu Lingyi Company Information
  3. 8.1.2 Baidu Lingyi Business Overview
  4. 8.1.3 Baidu Lingyi Ophthalmic AI-assisted Diagnosis Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Baidu Lingyi Ophthalmic AI-assisted Diagnosis Product Portfolio
  6. 8.1.5 Baidu Lingyi Recent Developments
  7. 8.2 Tencent Health
  8. 8.2.1 Tencent Health Company Information
  9. 8.2.2 Tencent Health Business Overview
  10. 8.2.3 Tencent Health Ophthalmic AI-assisted Diagnosis Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Tencent Health Ophthalmic AI-assisted Diagnosis Product Portfolio
  12. 8.2.5 Tencent Health Recent Developments
  13. 8.3 VoxelCloud
  14. 8.3.1 VoxelCloud Company Information
  15. 8.3.2 VoxelCloud Business Overview
  16. 8.3.3 VoxelCloud Ophthalmic AI-assisted Diagnosis Revenue and Gross Margin (2021-2026)
  17. 8.3.4 VoxelCloud Ophthalmic AI-assisted Diagnosis Product Portfolio
  18. 8.3.5 VoxelCloud Recent Developments
  19. 8.4 Wision
  20. 8.4.1 Wision Company Information
  21. 8.4.2 Wision Business Overview
  22. 8.4.3 Wision Ophthalmic AI-assisted Diagnosis Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Wision Ophthalmic AI-assisted Diagnosis Product Portfolio
  24. 8.4.5 Wision Recent Developments
  25. 8.5 ZHENHEALTH
  26. 8.5.1 ZHENHEALTH Company Information
  27. 8.5.2 ZHENHEALTH Business Overview
  28. 8.5.3 ZHENHEALTH Ophthalmic AI-assisted Diagnosis Revenue and Gross Margin (2021-2026)
  29. 8.5.4 ZHENHEALTH Ophthalmic AI-assisted Diagnosis Product Portfolio
  30. 8.5.5 ZHENHEALTH Recent Developments
  31. 8.6 Acer Medical
  32. 8.6.1 Acer Medical Company Information
  33. 8.6.2 Acer Medical Business Overview
  34. 8.6.3 Acer Medical Ophthalmic AI-assisted Diagnosis Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Acer Medical Ophthalmic AI-assisted Diagnosis Product Portfolio
  36. 8.6.5 Acer Medical Recent Developments
  37. 8.7 IMLINCS
  38. 8.7.1 IMLINCS Company Information
  39. 8.7.2 IMLINCS Business Overview
  40. 8.7.3 IMLINCS Ophthalmic AI-assisted Diagnosis Revenue and Gross Margin (2021-2026)
  41. 8.7.4 IMLINCS Ophthalmic AI-assisted Diagnosis Product Portfolio
  42. 8.7.5 IMLINCS Recent Developments
  43. 8.8 Vistel
  44. 8.8.1 Vistel Company Information
  45. 8.8.2 Vistel Business Overview
  46. 8.8.3 Vistel Ophthalmic AI-assisted Diagnosis Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Vistel Ophthalmic AI-assisted Diagnosis Product Portfolio
  48. 8.8.5 Vistel Recent Developments
  49. 8.9 Airdoc
  50. 8.9.1 Airdoc Company Information
  51. 8.9.2 Airdoc Business Overview
  52. 8.9.3 Airdoc Ophthalmic AI-assisted Diagnosis Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Airdoc Ophthalmic AI-assisted Diagnosis Product Portfolio
  54. 8.9.5 Airdoc Recent Developments
  55. 8.10 Shenzhen SiSensing
  56. 8.10.1 Shenzhen SiSensing Company Information
  57. 8.10.2 Shenzhen SiSensing Business Overview
  58. 8.10.3 Shenzhen SiSensing Ophthalmic AI-assisted Diagnosis Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Shenzhen SiSensing Ophthalmic AI-assisted Diagnosis Product Portfolio
  60. 8.10.5 Shenzhen SiSensing Recent Developments
  61. 8.11 WeDoctor
  62. 8.11.1 WeDoctor Company Information
  63. 8.11.2 WeDoctor Business Overview
  64. 8.11.3 WeDoctor Ophthalmic AI-assisted Diagnosis Revenue and Gross Margin (2021-2026)
  65. 8.11.4 WeDoctor Ophthalmic AI-assisted Diagnosis Product Portfolio
  66. 8.11.5 WeDoctor Recent Developments
  67. 8.12 Altris, Inc
  68. 8.12.1 Altris, Inc Company Information
  69. 8.12.2 Altris, Inc Business Overview
  70. 8.12.3 Altris, Inc Ophthalmic AI-assisted Diagnosis Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Altris, Inc Ophthalmic AI-assisted Diagnosis Product Portfolio
  72. 8.12.5 Altris, Inc Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst